Innovations in Surgery & Cardiac Surgery

March 15, 2022

About This Event

When Shark Tank and Open Mic Night had a baby, it was called Pitch Club. These one hour events occur every two weeks and are designed to showcase innovative startups while enabling them to get questions and feedback from Clinicians and Investors. The preparation is valuable and the exposure is priceless. Competition for the slots is high. Clinicians and Investors are able to network with the entrepreneurs after the events and this often leads to advisory and investment opportunities.

Hosted By

Jennifer Arthur

Membership, AngelMD, Inc

Guest Hosts

Dr. Ed Zuckerberg

Oral Care CAB Co-Chair, AngelMD, Inc
Edward J. Zuckerberg, D.D.S.,F.A.G.D. is a 1978 Graduate of NYU College of Dentistry. He owned his own practices in Brooklyn and Dobbs Ferry, NY from 1979-2013 and has always been an early adopter of technology, introducing his first PC in the office in 1986 and completely fully networking his home-based office with broadband access in 1996. Dr. Zuckerberg’s early adoption of technologies including digital radiography, CAD/CAM & creation of a paperless office caught the attention of industry leaders who enlisted him to lecture, write articles and beta test new technologies.

Dr. Jeremy Krell

Oral Care CAB Co-Chair, AngelMD, Inc
Highly experienced investor and entrepreneur with proven track record in taking early-stage startups to acquisition/multi-million dollar buyout. Detail orientated and strategic leader with firm experience in marketing, strategy, positioning companies, leading and developing teams, raising capital, investor relations, dental materials and techniques, negotiating and closing deals, and sales. Excellent clinical dentist with in-depth analytical, organizational and problem solving abilities.

Guest Speakers

greg-pic.jpg

Greg Aber

CEO/CTO, Corvion
Sonify is building better equipment to de-skill hyperthermia, a broadly active proven cancer therapy that treats many types of tumors. Despite decades of positive patient outcomes, existing US billing codes, and full Medicare reimbursement, less than 1% of eligible patients receive hyperthermia.

Greg Grover, PhD

CEO & Co-Founder, Karios Technologies, Inc
I am an experienced entrepreneur with extensive technical expertise in translating injectables and biomaterials into the clinic. Previously, I invented an injectable hydrogel for use as a male contraceptive device and translated it to the clinic in 4 years as well as raising >$18M in funding. My passion is building teams and innovative, paradigm changing products that will positively impact humanity and patients. As CEO and Co-Founder of Karios our mission is to protect patients from adhesions.

Almog Aley-Raz

CEO & VP R&D , CorNeat
I am an experienced entrepreneur with extensive technical expertise in translating injectables and biomaterials into the clinic. Previously, I invented an injectable hydrogel for use as a male contraceptive device and translated it to the clinic in 4 years as well as raising >$18M in funding. My passion is building teams and innovative, paradigm changing products that will positively impact humanity and patients. As CEO and Co-Founder of Karios our mission is to protect patients from adhesions.

Presenting Companies

Corvion
Karios Technologies, Inc
CorNeat